Page last updated: 2024-08-26

arsenic and Carcinoma, Transitional Cell

arsenic has been researched along with Carcinoma, Transitional Cell in 43 studies

Research

Studies (43)

TimeframeStudies, this research(%)All Research%
pre-19903 (6.98)18.7374
1990's0 (0.00)18.2507
2000's23 (53.49)29.6817
2010's13 (30.23)24.3611
2020's4 (9.30)2.80

Authors

AuthorsStudies
Cedrone, F; Di Giovanni, P; Di Martino, G; Lucisano, G; Meo, F; Romano, F; Scampoli, P; Staniscia, T1
Chang, CW; Chen, YT; Cheng, PY; Huang, HC; Lee, HY; Li, CC; Lo, CW; Ou, CH; Tsai, CY; Wu, CC; Yu, CC1
Chung, CJ; Hsueh, YM; Huang, CY; Huang, YK; Lai, LA; Lin, YC; Pu, YS; Shiue, HS; Su, CT; Wu, CC1
Dalley, CD; Ezaydi, Y; Goepel, JR; Kirkbride, P; Krishna, R; Smith, DJ; Snowden, JA; Sorour, Y1
Cao, L; Dunlevy, JR; Garrett, SH; Sens, DA; Sens, MA; Somji, S; Zheng, Y; Zhou, XD1
Chen, J; Guan, JY; Hour, TC; Huang, CY; Lu, SH; Pu, YS2
Chen, YC; Christiani, DC; Guo, YL; Hsueh, YM; Lee, MS; Ryan, LM; Smith, TJ; Su, HJ1
Diwan, BA; Liu, J; Waalkes, MP1
Chen, CJ; Chen, SY; Hsu, LI; Hsueh, YM; Huang, YK; Huang, YL; Wu, MM; Yang, MH1
Bredfeldt, TG; Eblin, KE; Gandolfi, AJ1
Low-Beer, TS; Robertson, DA1
Atkinson, SC1
Bin, PJ; Chai, CY; Chang, SJ; Luo, CW1
Chang, CH; Chung, CJ; Chung, MC; Hsu, HT; Lee, HL; Liu, CS; Wu, CD1
Kao, YT; Lan, SH; Liu, HS; Tseng, YS; Wu, CH; Wu, SY1
Chen, CH; Dai, YC; Haque, MM; Lin, LC; Lin, WH; Liu, YW; Wang, SC1
Chang, YH; Pang, ST; Shao, IH1
Cherry, N; Mostafa, MG2
Chai, CY; Chen, YT; Liu, XP; Wu, CC1
Chen, CJ; Chiu, AW; Chung, CJ; Hsueh, YM; Huang, SK; Huang, YK; Pu, YS; Tsai, HJ; Yang, MH1
Chen, YT; Chung, CJ; Hsueh, YM; Huang, CJ; Huang, YK; Pu, YS; Su, CT1
Chen, CH; Chen, CJ; Chiou, HY; Hsueh, YM; Pu, YS; Yu, HJ1
Chen, HW; Chung, CJ; Hsueh, YM; Huang, YK; Pu, YS; Shiue, HS; Su, CT1
Chen, SC; Chen, WC; Chu, PY; Chung, TW; Kan, WC; Su, SB; Tan, LB; Tyan, YC; Wang, HY; Yang, MH1
Chen, SC; Chen, WC; Chung, TW; Jong, SB; Liao, PC; Tyan, YC; Yang, MH; Yang, YH1
Chung, CJ; Hsueh, YM; Huang, CY; Lee, HL; Lin, P; Pu, YS; Su, CT; Wu, CC1
Chung, CJ; Hsueh, YM; Huang, CY; Pu, YS; Shiue, HS; Su, CT1
Choe, YB; Park, JY; Rim, JH; Youn, JI1
Demidenko, E; Heaney, J; Karagas, MR; Morris, JS; Mott, LA; Schned, A; Tosteson, TD1
Chen, YC; Christiani, DC; Guo, YL; Houseman, EA; Su, HJ1
Chen, CJ; Chen, CL; Chen, CY; Chen, SY; Cheng, YC; Chiou, HY; Chou, WL; Hsu, LI; Hsu, YH; Hsueh, YM; Lee, CY; Lin, YC; Shih, WL; Tseng, MP; Wang, CH; Wang, LH; Wang, YH; Wu, MM1
Andrew, A; Danaee, H; Karagas, MR; Kelsey, KT; Liu, M; Marsit, CJ; Nelson, HH; Schned, A1
Garrett, SH; Namburi, VB; Sens, DA; Sens, MA; Singh, RK; Somji, S; Zhou, XD1
Chiou, SH; Chou, MC; Chow, KC; Huang, HH; Lin, TS; Lin, TY; Tai, HL1
Böcher, A; Buchter, A; Müller, M1
Chen, CJ; Chen, CL; Chiu, AW; Chou, WL; Hsieh, FI; Hsu, LI; Huan, SK; Wang, LH; Wang, YH1
Chen, CJ; Chiu, AW; Hsiao, CH; Hsieh, FI; Hsu, LI; Huan, SK; Pu, YS; Wang, YH1
Chen, CJ; Chiou, HY; Chiou, ST; Chou, YL; Hsu, YH; Tseng, CH; Wei, ML1
Cantor, KP1
Stöhrer, G1
Fujioka, H; Kaihara, H; Kitamura, K; Koh, E; Kondoh, N1

Reviews

4 review(s) available for arsenic and Carcinoma, Transitional Cell

ArticleYear
Arsenic Exposure and Risk of Urothelial Cancer: Systematic Review and Meta-Analysis.
    International journal of environmental research and public health, 2020, 04-29, Volume: 17, Issue:9

    Topics: Arsenic; Arsenicals; Carcinoma, Transitional Cell; Environmental Exposure; Humans; Observational Studies as Topic; Urologic Neoplasms

2020
Immortalized human urothelial cells as a model of arsenic-induced bladder cancer.
    Toxicology, 2008, Jun-27, Volume: 248, Issue:2-3

    Topics: Animals; Arsenicals; Carcinogens; Carcinoma, Transitional Cell; Cell Line, Transformed; Cell Transformation, Neoplastic; Humans; Models, Biological; Urinary Bladder Neoplasms; Urothelium

2008
Recent advances in upper tract urothelial carcinomas: From bench to clinics.
    International journal of urology : official journal of the Japanese Urological Association, 2019, Volume: 26, Issue:2

    Topics: Animals; Antineoplastic Agents; Aristolochic Acids; Arsenic; Carcinogens; Carcinoma, Transitional Cell; Disease Models, Animal; Drinking Water; Drugs, Chinese Herbal; Humans; Immunotherapy; Incidence; Kidney Neoplasms; Nephrectomy; Risk Factors; Taiwan; Ureteral Neoplasms; Ureteroscopy

2019
Biomarkers of exposure, effect, and susceptibility of arsenic-induced health hazards in Taiwan.
    Toxicology and applied pharmacology, 2005, Aug-07, Volume: 206, Issue:2

    Topics: Arsenic; Biomarkers; Carcinoma, Transitional Cell; Carotenoids; Chromosome Aberrations; Environmental Monitoring; Genes, p53; Genomic Instability; Hair; Hazardous Substances; Humans; Loss of Heterozygosity; Mutation; Nails; Oxidative Stress

2005

Other Studies

39 other study(ies) available for arsenic and Carcinoma, Transitional Cell

ArticleYear
Comparative analysis of patients with upper urinary tract urothelial carcinoma in black-foot disease endemic and non-endemic area.
    BMC cancer, 2021, Jan-19, Volume: 21, Issue:1

    Topics: Aged; Arsenicals; Carcinoma, Transitional Cell; Disease-Free Survival; Endemic Diseases; Female; Geography; Humans; Incidence; Kidney Neoplasms; Male; Middle Aged; Peripheral Vascular Diseases; Prognosis; Retrospective Studies; Risk Factors; Taiwan; Ureteral Neoplasms; Water Pollution, Chemical

2021
Polymorphism of inflammatory genes and arsenic methylation capacity are associated with urothelial carcinoma.
    Toxicology and applied pharmacology, 2013, Oct-01, Volume: 272, Issue:1

    Topics: Aged; Arsenicals; Carcinoma, Transitional Cell; Case-Control Studies; Dose-Response Relationship, Drug; Female; Genotype; Humans; Inflammation; Interleukin-6; Interleukin-8; Male; Methylation; Middle Aged; Polymorphism, Genetic; Regression Analysis; Risk; Socioeconomic Factors; Surveys and Questionnaires; Tumor Necrosis Factor-alpha; Urologic Neoplasms

2013
Histopathological response of transitional cell carcinoma to arsenic trioxide during the treatment of concurrently diagnosed acute promyelocytic leukaemia.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 2008, Volume: 20, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Carcinoma, Transitional Cell; Female; Humans; Leukemia, Promyelocytic, Acute; Middle Aged; Neoplasms, Multiple Primary; Oxides; Remission Induction; Tretinoin; Urinary Bladder Neoplasms

2008
Keratin 6 expression correlates to areas of squamous differentiation in multiple independent isolates of As(+3)-induced bladder cancer.
    Journal of applied toxicology : JAT, 2010, Volume: 30, Issue:5

    Topics: Animals; Arsenic Trioxide; Arsenicals; Biomarkers, Tumor; Carcinogens; Carcinoma, Transitional Cell; Cell Line, Transformed; Cell Line, Tumor; Cell Transformation, Neoplastic; Gene Expression Regulation, Neoplastic; Humans; Keratin-6; Mice; Mice, Nude; Neoplasm Transplantation; Oxides; Urinary Bladder Neoplasms; Urothelium

2010
Cytotoxicity of arsenic trioxide to transitional carcinoma cells.
    Urology, 2002, Volume: 60, Issue:2

    Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Buthionine Sulfoximine; Carcinoma, Transitional Cell; Cisplatin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Glutathione; Humans; Oxides; Tumor Cells, Cultured; Urinary Bladder Neoplasms

2002
Arsenic methylation and bladder cancer risk in Taiwan.
    Cancer causes & control : CCC, 2003, Volume: 14, Issue:4

    Topics: Aged; Arsenicals; Cacodylic Acid; Carcinoma, Transitional Cell; Case-Control Studies; Female; Humans; Male; Methylation; Middle Aged; Retrospective Studies; Risk Factors; Smoking; Taiwan; Urinary Bladder Neoplasms; Water Pollution, Chemical; Water Supply

2003
Transplacental arsenic carcinogenesis in mice.
    Toxicology and applied pharmacology, 2007, Aug-01, Volume: 222, Issue:3

    Topics: Animals; Anticarcinogenic Agents; Arsenic; Arsenicals; Carcinogens; Carcinoma, Transitional Cell; Data Interpretation, Statistical; Diethylstilbestrol; Dose-Response Relationship, Drug; Drug Synergism; Estrogens; Female; Gene Expression Regulation, Neoplastic; Male; Maternal-Fetal Exchange; Mice; Mice, Inbred C3H; Neoplasms; Pregnancy; Prenatal Exposure Delayed Effects; Signal Transduction; Skin Neoplasms; Tamoxifen; Tetradecanoylphorbol Acetate; Urinary Bladder Neoplasms

2007
Arsenic exposure, urinary arsenic speciation, and the incidence of urothelial carcinoma: a twelve-year follow-up study.
    Cancer causes & control : CCC, 2008, Volume: 19, Issue:8

    Topics: Adult; Aged; Arsenic; Arsenic Poisoning; Arsenicals; Cacodylic Acid; Carcinoma, Transitional Cell; Case-Control Studies; Chromatography, High Pressure Liquid; Cohort Studies; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Prospective Studies; Spectrophotometry, Atomic; Surveys and Questionnaires; Taiwan; Time Factors; Urinary Bladder Neoplasms

2008
Long term consequences of arsenical treatment for multiple sclerosis.
    British medical journal (Clinical research ed.), 1983, Feb-19, Volume: 286, Issue:6365

    Topics: Adult; Arsenic; Arsenic Trioxide; Arsenicals; Carcinoma, Transitional Cell; Humans; Hypertension, Portal; Male; Multiple Sclerosis; Oxides; Urinary Bladder Neoplasms

1983
Arsenic trioxide as a novel anticancer agent against human transitional carcinoma--characterizing its apoptotic pathway.
    Anti-cancer drugs, 2002, Volume: 13, Issue:3

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Buthionine Sulfoximine; Carcinoma, Transitional Cell; Caspase 3; Caspases; Cisplatin; DNA, Neoplasm; Drug Resistance, Neoplasm; Enzyme Activation; G1 Phase; Humans; Membrane Potentials; Mitochondria; Oxides; Reactive Oxygen Species; Signal Transduction; Tumor Cells, Cultured; Urinary Bladder Neoplasms

2002
Arsenical keratoses and internal cancer (urinary bladder and nasopharynx).
    Archives of dermatology, 1969, Volume: 99, Issue:2

    Topics: Arsenicals; Carcinoma, Transitional Cell; Female; Humans; Keratosis; Middle Aged; Nasopharyngeal Neoplasms; Urinary Bladder Neoplasms

1969
CHD4 plays a critical role in arsenite-induced oxidative damage in human urothelial carcinoma.
    Pathology, research and practice, 2022, Volume: 240

    Topics: Arsenic; Arsenites; Carcinoma, Transitional Cell; DNA Damage; Humans; Mi-2 Nucleosome Remodeling and Deacetylase Complex; Oxidative Stress; Urinary Bladder Neoplasms

2022
Determination of potential sources of heavy metals in patients with urothelial carcinoma in central Taiwan: a biomonitoring case-control study.
    Environmental geochemistry and health, 2023, Volume: 45, Issue:7

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Arsenic; Biological Monitoring; Cadmium; Carcinoma, Transitional Cell; Case-Control Studies; Cobalt; Copper; Environmental Monitoring; Humans; Metals, Heavy; Nickel; Particulate Matter; Taiwan; Urinary Bladder Neoplasms

2023
Arsenic treatment increase Aurora-A overexpression through E2F1 activation in bladder cells.
    BMC cancer, 2017, 04-18, Volume: 17, Issue:1

    Topics: Animals; Arsenic; Aurora Kinase A; Blotting, Western; Carcinogenesis; Carcinoma, Transitional Cell; Cell Line, Tumor; Cell Proliferation; Chromatin Immunoprecipitation; E2F1 Transcription Factor; Flow Cytometry; Fluorescent Antibody Technique; Humans; Immunohistochemistry; Mice; Mice, Inbred BALB C; Reverse Transcriptase Polymerase Chain Reaction; Urinary Bladder Neoplasms

2017
The interaction of arsenic and N-butyl-N-(4-hydroxybutyl)nitrosamine on urothelial carcinogenesis in mice.
    PloS one, 2017, Volume: 12, Issue:10

    Topics: Animals; Arsenic; Butylhydroxybutylnitrosamine; Carcinogenesis; Carcinogens; Carcinoma, Transitional Cell; Carrier Proteins; Cyclin-Dependent Kinase Inhibitor p21; Drug Interactions; Female; Gene Expression Regulation, Neoplastic; Glutathione Transferase; Male; Mice; Mice, Inbred C57BL; NAD(P)H Dehydrogenase (Quinone); Sp1 Transcription Factor; Urinary Bladder; Urinary Bladder Neoplasms; Urothelium

2017
Arsenic in drinking water and renal cancers in rural Bangladesh.
    Occupational and environmental medicine, 2013, Volume: 70, Issue:11

    Topics: Adolescent; Adult; Aged; Arsenic; Bangladesh; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Drinking Water; Environmental Exposure; Female; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Risk Factors; Rural Population; Smoking; Surveys and Questionnaires; Water Pollutants, Chemical; Water Supply; Water Wells; Young Adult

2013
Arsenic in Drinking Water, Transition Cell Cancer and Chronic Cystitis in Rural Bangladesh.
    International journal of environmental research and public health, 2015, Oct-28, Volume: 12, Issue:11

    Topics: Arsenic; Bangladesh; Carcinoma, Transitional Cell; Chronic Disease; Cystitis; Drinking Water; Female; Humans; Logistic Models; Male; Neoplasms; Odds Ratio; Rural Population; Urologic Neoplasms; Water Supply; Water Wells

2015
Aberrant β-catenin expression in urothelial carcinomas in blackfoot disease-endemic areas.
    The Kaohsiung journal of medical sciences, 2017, Volume: 33, Issue:1

    Topics: Aged; Antigens, CD; Arsenic; beta Catenin; Cadherins; Carcinoma, Transitional Cell; Cell Membrane; Cytosol; Endemic Diseases; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Membrane Proteins; Middle Aged; Protein Transport; Taiwan; Urologic Neoplasms; Urothelium; Water Pollutants, Chemical

2017
Arsenic methylation capability, heme oxygenase-1 and NADPH quinone oxidoreductase-1 genetic polymorphisms and the stage and grade of urothelial carcinomas.
    Urologia internationalis, 2008, Volume: 80, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Arsenic; Arsenic Poisoning; Carcinoma, Transitional Cell; Cohort Studies; DNA Methylation; Environmental Exposure; Female; Humans; Incidence; Male; Middle Aged; NADH, NADPH Oxidoreductases; Neoplasm Staging; Polymorphism, Genetic; Probability; Prognosis; Risk Assessment; Survival Analysis; Taiwan; Urinary Bladder Neoplasms

2008
Polymorphisms in cell cycle regulatory genes, urinary arsenic profile and urothelial carcinoma.
    Toxicology and applied pharmacology, 2008, Oct-15, Volume: 232, Issue:2

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Arsenic; Carcinoma, Transitional Cell; Case-Control Studies; Cyclin D; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Deoxyguanosine; Female; Genes, cdc; Genetic Variation; Humans; Male; Middle Aged; Polymorphism, Genetic; Tumor Suppressor Protein p53; Urinary Bladder Neoplasms

2008
Clinicopathological characteristics and survival outcome of arsenic related bladder cancer in taiwan.
    The Journal of urology, 2009, Volume: 181, Issue:2

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Arsenic; Arsenic Poisoning; Carcinoma, Transitional Cell; Cohort Studies; Drinking; Environmental Exposure; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Probability; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Sex Factors; Survival Analysis; Taiwan; Urinary Bladder Neoplasms; Water Supply

2009
Polymorphisms in one-carbon metabolism pathway genes, urinary arsenic profile, and urothelial carcinoma.
    Cancer causes & control : CCC, 2010, Volume: 21, Issue:10

    Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Aged; Arsenic; Cacodylic Acid; Carcinoma, Transitional Cell; Case-Control Studies; Cystathionine beta-Synthase; Female; Folic Acid; Genotype; Homocysteine; Humans; Life Style; Male; Metabolic Networks and Pathways; Methylation; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Single Nucleotide; Risk Factors; Socioeconomic Factors; Taiwan; Urinary Bladder Neoplasms

2010
Characterization of ADAM28 as a biomarker of bladder transitional cell carcinomas by urinary proteome analysis.
    Biochemical and biophysical research communications, 2011, Aug-12, Volume: 411, Issue:4

    Topics: ADAM Proteins; Aged; Aged, 80 and over; Amino Acid Sequence; Arsenic; Biomarkers, Tumor; Blotting, Western; Carcinoma, Transitional Cell; Female; Humans; Male; Middle Aged; Molecular Sequence Data; Proteome; Proteomics; Urinary Bladder Neoplasms

2011
Urinary protein profiling by liquid chromatography/tandem mass spectrometry: ADAM28 is overexpressed in bladder transitional cell carcinoma.
    Rapid communications in mass spectrometry : RCM, 2011, Oct-15, Volume: 25, Issue:19

    Topics: ADAM Proteins; Adult; Aged; Aged, 80 and over; Amino Acid Sequence; Arsenic; Biomarkers, Tumor; Carcinoma, Transitional Cell; Case-Control Studies; Chromatography, Liquid; Female; Humans; Male; Middle Aged; Molecular Sequence Data; Peptide Fragments; Peripheral Vascular Diseases; Proteinase Inhibitory Proteins, Secretory; Proteins; Proteinuria; Proteome; Proteomics; Reproducibility of Results; Sensitivity and Specificity; Serine Peptidase Inhibitor Kazal-Type 5; Taiwan; Tandem Mass Spectrometry; Urinary Bladder Neoplasms

2011
Joint effect of arsenic methylation profile and NNK metabolites on urothelial carcinoma.
    The Journal of urology, 2012, Volume: 188, Issue:5

    Topics: Arsenic; Carcinoma, Transitional Cell; Case-Control Studies; Humans; Methylation; Nitrosamines; Pyridines; Risk; Smoking; Urologic Neoplasms

2012
The effect of cigarette smoke and arsenic exposure on urothelial carcinoma risk is modified by glutathione S-transferase M1 gene null genotype.
    Toxicology and applied pharmacology, 2013, Jan-15, Volume: 266, Issue:2

    Topics: Arsenic; Carcinoma, Transitional Cell; Case-Control Studies; Chromatography, High Pressure Liquid; Environmental Exposure; Female; Genotype; Glutathione Transferase; Humans; Life Style; Logistic Models; Male; Middle Aged; Multivariate Analysis; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Risk Factors; Smoking; Spectrophotometry, Atomic; Tobacco Smoke Pollution

2013
Arsenic keratosis and pigmentation accompanied by multiple Bowen's disease and genitourinary cancer in a psoriasis patient.
    The Journal of dermatology, 2002, Volume: 29, Issue:7

    Topics: Arsenic; Bowen's Disease; Carcinoma, Transitional Cell; Drug Therapy, Combination; Follow-Up Studies; Hand Dermatoses; Humans; Immunohistochemistry; Keratolytic Agents; Keratosis; Male; Middle Aged; Risk Assessment; Skin Neoplasms; Treatment Outcome; Urinary Bladder; Urogenital Neoplasms

2002
Incidence of transitional cell carcinoma of the bladder and arsenic exposure in New Hampshire.
    Cancer causes & control : CCC, 2004, Volume: 15, Issue:5

    Topics: Adult; Aged; Arsenic; Carcinogens; Carcinoma, Transitional Cell; Case-Control Studies; Female; Humans; Incidence; Male; Middle Aged; New Hampshire; Odds Ratio; Registries; Smoking; Urinary Bladder Neoplasms; Water Supply

2004
Interaction between environmental tobacco smoke and arsenic methylation ability on the risk of bladder cancer.
    Cancer causes & control : CCC, 2005, Volume: 16, Issue:2

    Topics: Aged; Air Pollutants; Arsenic; Carcinoma, Transitional Cell; Case-Control Studies; Cataract; Environmental Pollutants; Female; Fractures, Bone; Humans; Inactivation, Metabolic; Male; Methylation; Middle Aged; Risk Factors; Sex Factors; Smoking; Taiwan; Tobacco Smoke Pollution; Urinary Bladder Neoplasms; Water Pollutants, Chemical

2005
Carcinogen exposure and gene promoter hypermethylation in bladder cancer.
    Carcinogenesis, 2006, Volume: 27, Issue:1

    Topics: Adult; Aged; Arsenic; Carcinoma, Transitional Cell; Cyclin-Dependent Kinase Inhibitor p16; DNA Methylation; Female; Gene Silencing; Genotype; Humans; Male; Middle Aged; New Hampshire; Polymerase Chain Reaction; Promoter Regions, Genetic; Smoking; Trypsin; Tumor Suppressor Protein p53; Tumor Suppressor Proteins; Urinary Bladder Neoplasms

2006
Metallothionein-1 and -2 expression in cadmium- or arsenic-derived human malignant urothelial cells and tumor heterotransplants and as a prognostic indicator in human bladder cancer.
    Toxicological sciences : an official journal of the Society of Toxicology, 2006, Volume: 91, Issue:2

    Topics: Animals; Arsenic; Biomarkers, Tumor; Cadmium; Carcinoma, Transitional Cell; Cell Line, Transformed; Gene Expression Regulation, Neoplastic; Humans; Metallothionein; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Transplantation; Prognosis; RNA, Messenger; Urinary Bladder Neoplasms; Urothelium

2006
Overexpression of aldo-keto reductase 1C2 as a high-risk factor in bladder cancer.
    Oncology reports, 2007, Volume: 17, Issue:2

    Topics: Adult; Arsenic; Carcinoma, Transitional Cell; Disease Progression; Drug Resistance, Neoplasm; Female; Humans; Hydroxysteroid Dehydrogenases; Immunohistochemistry; Male; Middle Aged; Phenotype; Risk; Sequence Analysis, DNA; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Urinary Bladder Neoplasms

2007
[Induction of urothelial carcinoma due to chronic arsenic ingestion? A occupational medicine-toxicological excursion].
    Der Urologe. Ausg. A, 2007, Volume: 46, Issue:5

    Topics: Administration, Oral; Arsenic; Arsenic Poisoning; Carcinoma, Transitional Cell; Cross-Sectional Studies; Environmental Exposure; Germany; Humans; Kidney Neoplasms; Occupational Diseases; Occupational Exposure; Risk Factors; Urinary Bladder Neoplasms; Water Pollutants, Chemical

2007
SNPs of GSTM1, T1, P1, epoxide hydrolase and DNA repair enzyme XRCC1 and risk of urinary transitional cell carcinoma in southwestern Taiwan.
    Toxicology and applied pharmacology, 2008, Apr-15, Volume: 228, Issue:2

    Topics: Adult; Aged; Arsenic; Carcinoma, Transitional Cell; Case-Control Studies; DNA-Binding Proteins; Environmental Exposure; Epoxide Hydrolases; Female; Genetic Predisposition to Disease; Glutathione S-Transferase pi; Glutathione Transferase; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Polymorphism, Single Nucleotide; Risk Factors; Taiwan; Urologic Neoplasms; Water Pollutants, Chemical; X-ray Repair Cross Complementing Protein 1

2008
Comparative genomic hybridization study of arsenic-exposed and non-arsenic-exposed urinary transitional cell carcinoma.
    Toxicology and applied pharmacology, 2008, Mar-01, Volume: 227, Issue:2

    Topics: Adult; Arsenic; Carcinoma, Transitional Cell; Chromosome Aberrations; Chromosomes, Human, Pair 17; DNA; Female; Gene Dosage; Genes, p53; Humans; Hybridization, Genetic; Immunohistochemistry; Male; Poisons; Regression Analysis; Smoking; Taiwan; Urinary Bladder Neoplasms; Water Supply

2008
Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan.
    American journal of epidemiology, 2001, Mar-01, Volume: 153, Issue:5

    Topics: Adult; Arsenic; Carcinoma, Transitional Cell; Cohort Studies; Dose-Response Relationship, Drug; Environmental Exposure; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Risk Assessment; Taiwan; Urinary Bladder Neoplasms; Water Pollutants; Water Supply

2001
Invited commentary: arsenic and cancer of the urinary tract.
    American journal of epidemiology, 2001, Mar-01, Volume: 153, Issue:5

    Topics: Arsenic; Carcinoma, Transitional Cell; Cohort Studies; Humans; Prospective Studies; Risk Assessment; Urinary Bladder Neoplasms; Water Pollutants

2001
Arsenic levels can be "standard" or "safe".
    Science (New York, N.Y.), 2001, May-18, Volume: 292, Issue:5520

    Topics: Arsenic; Arsenic Poisoning; Carcinoma, Transitional Cell; Drinking; Humans; Reproducibility of Results; Risk Assessment; United States; Urologic Neoplasms; Water; Water Supply

2001
Ureteral tumor with multiple Bowen's disease forty-two years after exposure to arsenic.
    European urology, 1989, Volume: 16, Issue:5

    Topics: Aged; Arsenic; Bowen's Disease; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Humans; Male; Occupational Diseases; Skin Neoplasms; Time Factors; Ureteral Neoplasms

1989